Zacks Investment Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,526	Closed	-$123K	–	541
2018 Q3	$123K	Buy	+1,526	New	+$123K	﹤0.01%	499
2017 Q3	–	Sell	-4,209	Closed	-$147K	–	616
2017 Q2	$147K	Buy	+4,209	New	+$147K	﹤0.01%	557